Revolution Medicines' daraxonrasib is the first drug that can broadly tackle one of the main drivers of pancreatic cancer.
The FDA has approved Tukysa (tucatinib) combined with trastuzumab and pertuzumab for the maintenance treatment of adult ...
15hOpinion
Opinion: California has a chance to change the odds for cancer. Vote ‘yes’ on Prop. 38.
Their debate answers tell a different story now East Bay hospital workers stage ‘die-in’ to support billionaire wealth tax ...
A doctor reassures a thyroid cancer patient that radioactive iodine treatment poses minimal risk to organs like the heart and ...
Organizers aim to raise nearly $7 million for breast cancer research during October's NYC Race for the Cure.
TORONTO, Oct. 4, 2026 /CNW/ -- Today, more than 65,000 participants and volunteers across over 50 communities nationwide came together at the Canadian Cancer Society CIBC Run for the Cure, raising $18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results